Tag: IDRI

Amyris completes 1st major license for RNA COVID vaccine

Amyris completes 1st major license for RNA COVID vaccine

July 3, 2021 |

In California, Amyris, Inc. signed an exclusive license with Nant Africa, LLC relating to the development and use of the RNA COVID vaccine Amyris developed in coordination with the Infectious Disease Research Institute (IDRI). Amyris’ partnership with Nant Africa is of significant value to Amyris as it provides the fastest path to market for the […]

Read More